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The prevalence of cancer in the United States in 2012 was
13.7 million.1 According to the National Cancer Institute,2
approximately one half of all patients with cancer will
receive some sort of radiation therapy (RT) during the course
of their treatment. In a recent single-center case series,3
nearly 1% of patients receiving RT had cardiac implantable
electronic devices (CIEDs). We can therefore deduce that
there are a sizable number of patients receiving RT for cancer
who also have CIEDs.
Modern CIEDs use integrated circuits built with comple-
mentary metal-oxide-semiconductor technology, which
make them smaller, reliable, and energy efﬁcient but more
sensitive to ionizing radiation from RT, as compared with
older devices, which used nonprogrammable bipolar semi-
conductors.4 These effects range from mild programming
corruption to power-on-reset or even total device failure and
tend to increase with cumulative radiation exposure. RT
machines also cause electromagnetic interference or scatter
radiation of neutrons that can disrupt device function.5,6
Optimal management of patients with CIEDs undergoing
RT is unknown. We present a case of a patient with an
implantable cardioverter-deﬁbrillator (ICD) with single-coil
deﬁbrillator lead who required whole chest radiation and
demonstrate an innovative solution.Case report
A 69-year-old former smoker with coronary artery disease
status post–myocardial infarction in 1998 and ischemic
cardiomyopathy (left ventricular ejection fraction 10%–
15%) status post-ICD implantation in 2001 for inducibleKEYWORDS Radiation therapy; ICD; Pacemaker; Repositioning
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oncology, given plans for RT. His right ventricular (RV)
lead was a single-coil Medtronic Sprint model 6943
(Minneapolis, MN), and his right atrial lead was a Medtronic
CapSureFix model 4568, which has demonstrated progres-
sively falling impedances since implantation. Given the lack
of atrial pacing requirement, his system was programmed
to VVI mode. He was on amiodarone from 2001 to 2006,
which was discontinued because of reduced diffusing
capacity of the lung for carbon monoxide. He has a history
of appropriate ICD discharge and antitachycardia pacing
for recurrent monomorphic ventricular tachycardia. He
underwent ICD generator change in 2005 and 2013; his
most recent generator was a Medtronic Maximo II DR model
D284TRG (Figure 1).
In August 2015 he developed hoarseness with cervical
lymphadenopathy. A computed tomographic scan of the
chest showed a right upper lobe mass that was compressing
the laryngeal nerve. He was determined to have stage IIIb
adenocarcinoma of the lung. He started chemotherapy but
needed external beam radiation (photon therapy) to a large
bilateral thoracic ﬁeld to a dose of 60 Gy in 30 fractions;
therefore, the radiation oncologist requested repositioning of
the ICD generator. It was anticipated that with cancer
treatment his prognosis for survival would approach 3 years,
but treatment was unlikely to be curative.
Electrophysiological procedure
The patient was brought to the electrophysiology laboratory
in the fasting state. After informed consent was obtained, left
upper extremity venography was performed, which revealed
that the subclavian vein was completely occluded with
bridging collaterals. This precluded ipsilateral implantation
of a superior vena cava (SVC) coil or azygous lead to allow
for an RV coil - RV can/SVC deﬁbrillation option. The
decision was made to relocate the ICD to the left upper
quadrant and add a subcutaneous coil. A 6-cm
incision was made over the ICD header, carried down to
the device pocket, and the generator was removed. Thepen access article under the CC BY-NC-ND license
http://dx.doi.org/10.1016/j.hrcr.2016.04.009
KEY TEACHING POINTS
 There is no standard approach to dealing with
patients with cardiac implantable electronic
devices who need radiation therapy as they are
susceptible to both ionizing radiation and
electromagnetic interference in a non–dose-
dependent manner.
 In particular, those who need chest radiation are
problematic and we chose repositioning the
generator to the abdomen as a permanent solution.
An individualized approach is necessary, and we
present various options for implanters to consider.
 There are limited data on an active abdominal can
and single-coil deﬁbrillator lead conﬁguration, and
a subcutaneous lead will offer more deﬁbrillation
vectors.
Heart Rhythm Case Reports, Vol 2, No 5, September 2016396right atrial lead was capped, given a history of falling
impedances.
Next, an 8-cm incision was made in the left upper
quadrant and a subcutaneous pocket was created. The
chronic ICD lead IS-1 connector was attached to a 37-cm
Medtronic IS-1 lead extender model 6984M, which was then
tunneled to the abdominal pocket. The chronic ICD lead
DF-1 connector was attached to a 25-cm Medtronic DF-1
Y-Adaptor/Extender model 6726, which was then tunneled
to the abdominal pocket. A 41-cm Medtronic subcutaneous
coil model 6996SQ was tunneled from the pectoral pocket toFigure 1 Radiographic image of the original implantable cardioverter-
deﬁbrillator system in the anterior-posterior projection.the left side of the chest. The subcutaneous coil was
connected to a 25-cm Medtronic DF-1 Y-Adaptor/Extender
model 6726, which was then tunneled to the abdominal
pocket. A port plug was used in each DF-1 Y-adapter to
convert them into a straight (non-Y) extension. DF-1
Y-adapters used as no straight DF-1 adapters of equivalent
length were commercially available. The 3 lead extenders
were connected to a new Medtronic Evera S VR model
DVBC3D1 ICD, and the generator was placed into the
abdominal pocket (Figures 2, 3A, and 3B).
Next, deﬁbrillator threshold (DFT) testing was done;
ventricular ﬁbrillation was induced with a T-wave shock
and deﬁbrillated with a 30 J internal shock in the B4AX
(RV coil- RV can/subcutaneous coil) conﬁguration. Shock
impedance was 38 Ω. Both chest and abdominal wounds
were closed with 2-0 vicryl in layers, and the skin was
approximated with staples.Discussion
Management of patients with CIEDs who need RT can be
challenging. Unfortunately, there are no current national or
international standards or guidelines regarding CIEDs and
RT exposure. The American Association of Physicists in
Medicine published a consensus statement in 1994, which is
now outdated, although a new task force has been created to
address the issue.7,8 The complexity of RT (peak dose, total
cumulative dose, dose rate, scatter radiation, and concom-
itant electromagnetic ﬁelds) makes it difﬁcult to predict
device function and safety.9 The generally accepted safe
radiation dose is 2–10 Gy for pacemakers (PPMs) and o1
Gy for ICDs, which is well below the curative dose for
breast or lung cancer (50–60 Gy); there are reports of
CIED malfunction at low doses as well.9 We reviewed 2
of the largest in vivo studies of patients with CIEDs
undergoing RT.
Brambatti et al3 performed a single-center prospective
study of 261 patients with CIEDs undergoing RT. They were
classiﬁed as low risk (not PPM dependent, no chest radiation,
or cumulative doseo20 Gy), acute high risk (PPM depend-
ent), or chronic high risk (chest radiation and/or cumulative
dose 420 Gy). CIED relocation was recommended only if
cumulative dose 420 Gy or PPM dependent with a
cumulative dose of 2–20 Gy. Forty-one patients received
chest radiation contralateral to the CIED, 25 received chest
radiation ipsilateral to the CIED, and 15 received bilateral
chest radiation. Of the study cohort, 4 had inappropriate
device function. Three of these had radiation to the central
chest with total radiation dose o2 Gy. Of those 3, 1 (ICD)
had a power-on-reset and 2 (PPM) had maximum sensory
pacing. Therefore, it appears that with chest exposure, even
smaller doses of RT can affect CIEDs.
Zaremba et al9 performed a population-based multicenter
cohort study of 560 patients with CIEDs undergoing RT. Of
the 14 patients with device malfunctions, 4 received chest
RT, 7 received abdomen and pelvis RT, and the remaining
received RT to the head and neck, spine, or lower extremity.
Figure 2 Schematic of implantable cardioverter-deﬁbrillator (ICD) system with subcutaneous coil, DF-1 connectors, and IS-1 lead extenders.
DF  ¼ Deﬁbrillator cathode; DF þ ¼ Deﬁbrillator anode; RA ¼ right atrial; RV ¼ right ventricular.
397Karnik et al Abdominal ICD in Radiation TherapyThe median cumulative radiation dose associated with
device malfunctions was 46.5 Gy. Eleven of the device
malfunctions were power resets or minor software errors;
2 required a software update; and 1 had elevated atrialFigure 3 Radiographic images of the repositioned implantable cardioverter-deﬁb
the left upper quadrant in anterior-posterior (A) and lateral (B) projections. The Ythresholds. These errors occurred in 2.5% of patients with
PPMs and 6.8% of patients with ICDs.
Where and how to relocate CIEDs, when indicated, is not
well expounded upon in the literature. If unilateral chest RTrillator system with a subcutaneous coil and right ventricular lead tunneled to
-adapters are bracketed.
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side is reasonable. Our patient required bilateral chest
radiation, so this was not a possibility. For this patient, the
following options were considered:1. Explant the generator, apply a ZOLL LifeVest (Zoll
Medical Corporation, Chelmsford, MA), and reimplanta-
tion after radiation is completed.10 However, this exposes
the patient to an additional procedure and is reliant on
patient compliance with the LifeVest. In addition, if the
patient later needs further RT then they will be subjected
to additional procedures.2. Extract the entire ICD system while maintaining venous
access and implant a 100-cm Medtronic Sprint Quattro
dual-coil deﬁbrillator lead and tunnel to the left upper
quadrant. Given the patient’s comorbidities and limited
expected life span, this was felt to be too invasive with
signiﬁcant potential risk.3. Cap current system and implant a new right-sided 100-cm
Medtronic Sprint Quattro dual-coil deﬁbrillator lead and
tunnel to the right upper quadrant. However, this would
have required more transvenous hardware in the body and
required an additional incision with subsequent radiation
that may affect wound healing11 and infectious risk. Also,
radiation-induced venous stenosis and deep venous
thrombosis have been reported12 and recent endovascular
disruption on both sides may enhance this risk.4. Extend current lead to the left upper quadrant abdomen
without additional hardware. However, this would have
limited deﬁbrillation vectors to RV coil - RV can and
vice versa. There are limited data on the adequacy of
DFTs in single-coil systems with active abdominal
generators. Solomon et al13 studied 10 patients with left
abdominal ICDs with either dual-coil endocardial leads or
anterior and posterior epicardial patches undergoing
generator change. For the endocardial lead group
(n ¼ 3), they tested 3 deﬁbrillation vector conﬁgurations:
(i) passive can with RV- SVC; (ii) active can- RV;
(iii) active can- SVC. The last 2 conﬁgurations used a
Medtronic 5425 active can ICD emulator and excluded
1 electrode to simulate lead failure, that is, making it a
single-coil system. DFTs were 14.0  10.5 J for the
passive can conﬁguration, 14.0  9.2 J for the active can
- RV conﬁguration, and 19.7  9.7 J for the active can
- SVC conﬁguration. Given the paucity of data avail-
able, and since the pocket was already open and 2 lead
extenders had to be tunneled, we felt that adding the
subcutaneous coil had potential beneﬁt (RV coil- RV
can/subcutaneous coil deﬁbrillation vector) without much
additional risk (see option 5 below).5. Extend the current lead to the left upper quadrant and add
a subcutaneous coil via separate DF-1 connectors, given
occluded left subclavian vein. This is the option we chose.
To reduce hardware bulk we could have connected both
the subcutaneous and DF-1 leads to 1 Y-adapter, but this
would have limited deﬁbrillation vectors. A right-sidedSVC or azygous coil could have been placed and tunneled
to the left-sided abdominal generator via an extender,
but this would have required an additional incision
(see option 3 above) and transabdominal lead positioning.6. A totally subcutaneous ICD was not an option, as it would
still be in the thoracic cavity and therefore subject to
RT exposure as well as potentially restricting RT portal
access.
Conclusion
Much uncertainty exists about optimal management of
patients with CIEDs undergoing RT, given the lack of
current guidelines. ICDs appear to be particularly susceptible
to device damage from ionizing radiation and electromag-
netic interference during these treatments, not necessarily in
a dose-dependent manner. Device relocation is an option, but
no guidance is given in the literature. We present a solution
in a patient with a single-coil ICD lead who required whole
chest radiation, which consisted of placing a subcutaneous
coil with reimplantation of the generator in the upper
abdomen. We also present other potential conﬁgurations
and their downsides; ultimately an individualized approach
is essential.References
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